FILTERS
Primary Site
9 More...
Program
Disease Type
20 More...
Analytical Fraction
Experiment Type
Acquisition Type
Start searching by selecting a facet
Charts
ANALYTICAL FRACTIONS
0100020003000AcetylomeGlycoproteomeLipidomeMetabolomePhosphoproteomeProteomeUbiquitylomeCases
DISEASE TYPES
Ovarian Serous Cystadenocarcinoma: 12.3% Pancreatic Ductal Adenocarcinoma: 9.4% Lung Adenocarcinoma: 8% Breast Invasive Carcinoma: 8% Glioblastoma: 7.1% Other: 7% Pediatric/AYA Brain Tumors: 6.2% Acute Myeloid Leukemia: 6.2% Uterine Corpus Endometrial Carcinoma: 6.1% Clear Cell Renal Cell Carcinoma: 5.5% Hepatocellular Carcinoma: 4.3% Colon Adenocarcinoma: 4.1%
EXPERIMENT TYPES
050010001500iTRAQ4iTRAQ8Label FreeTMT10TMT11TMT6Cases

Total studies: 163

Export All Manifests   
Export Study Manifest     
10
PDC Study ID  Study Project Program Cases #
Available files for data category
Raw
Processed
Mass Spectra
MetadataPSM
Protein
Assembly
Quality
Metrics
PDC000553CPTAC GBM Discovery Study - LipidomeCPTAC3 Discovery and ConfirmatoryClinical Proteomic Tumor Analysis ConsortiumGlioblastoma; OtherBrainLipidomeLabel Free8316600N/AN/AN/A
PDC000552CPTAC GBM Discovery Study - MetabolomeCPTAC3 Discovery and ConfirmatoryClinical Proteomic Tumor Analysis ConsortiumGlioblastoma; OtherBrainMetabolomeLabel Free8383830N/AN/AN/A
PDC000547CPTAC GBM Confirmatory Study - LipidomeCPTAC3 Discovery and ConfirmatoryClinical Proteomic Tumor Analysis ConsortiumBreast Invasive Carcinoma; Glioblastoma; Gliomas; Lung Adenocarcinoma; Meningiomas; OtherBrain; Breast; Bronchus and lung; Not ReportedLipidomeLabel Free8217000N/AN/AN/A
PDC000546CPTAC GBM Confirmatory Study - MetabolomeCPTAC3 Discovery and ConfirmatoryClinical Proteomic Tumor Analysis ConsortiumBreast Invasive Carcinoma; Glioblastoma; Gliomas; Lung Adenocarcinoma; Meningiomas; OtherBrain; Breast; Bronchus and lung; Not ReportedMetabolomeLabel Free8588880N/AN/AN/A
PDC000544CPTAC non-ccRCC Study - MetabolomeCPTAC3 Discovery and ConfirmatoryClinical Proteomic Tumor Analysis ConsortiumNon-Clear Cell Renal Cell Carcinoma; OtherKidney; Not ReportedMetabolomeLabel Free3210602N/AN/AN/A
PDC000535CPTAC CCRCC Confirmatory Study - Validation - MetabolomeCPTAC3 Discovery and ConfirmatoryClinical Proteomic Tumor Analysis ConsortiumClear Cell Renal Cell CarcinomaKidneyMetabolomeLabel Free5614200N/AN/AN/A
PDC000534CPTAC CCRCC Confirmatory Study - Training - MetabolomeCPTAC3 Discovery and ConfirmatoryClinical Proteomic Tumor Analysis ConsortiumClear Cell Renal Cell Carcinoma; Non-Clear Cell Renal Cell Carcinoma; OtherKidney; Not ReportedMetabolomeLabel Free6114200N/AN/AN/A
PDC000527CPTAC PDAC Proteins in Serum - GlycoproteomeCPTAC3-OtherClinical Proteomic Tumor Analysis ConsortiumNot Applicable; Other; Pancreatic Ductal AdenocarcinomaNot Applicable; PancreasGlycoproteomeLabel Free11811801000
PDC000526CPTAC PDAC Proteins in Serum - ProteomeCPTAC3-OtherClinical Proteomic Tumor Analysis ConsortiumNot Applicable; Other; Pancreatic Ductal AdenocarcinomaNot Applicable; PancreasProteomeLabel Free11811801000
PDC000515KNCC Glioblastoma Evolution - PhosphoproteomeCancer Proteogenomics Group of National Cancer Center KoreaInternational Cancer Proteogenome ConsortiumGlioblastoma; OtherBrain; Not ApplicablePhosphoproteomeTMT1191264264052862
10

Warning